At the end of today's trading session, the stock was quoted at Rs 984.40, up 2.67%
India and island city have agreed on a new double-tax avoidance treaty, which is likely to be notified soon
The first attempt to auction the valley was a disaster as just two bidders were reportedly in the fray in the initial stages and even these did not turn up for inspection
Fund houses are restricting such investments; heed the signal and stick to SIPs and STPs
Foreign portfolio investors (FPI) were strong net buyers in November along with domestic institutions. But, FPIs have been net sellers in the December settlement
Nifty, Bank Nifty, Bharti Infratel, Coal India, Hindustan Unilever
Major gainers were HUL 1.37%, HDFC with 1.25% and Tata Motors with 1.06%
Higher demand and product launches should drive volumes & market share
Parekh says investors should temper their return expectations as interest rates have fallen over the past three years and valuations have stretched considerably
After deleveraging, the Street will watch out for the pace of inventory sale
Players with a strong balance sheet, execution track record, and robust asset portfolio would be key beneficiaries
NSE's IPO is being keenly awaited in the market as one of the biggest in recent times
All that happened in today's trade
The stock locked in lower circuit of 5% at Rs 131, down 7% from intra-day high on the BSE.
Setco Automotive hit a 52-week high of Rs 48.40, up 15% on the BSE in intra-day trade after the company reported a standalone net profit of Rs 13.76 crore in Q2 against loss of Rs 11.89 crore in Q1.
As EPC remains preferred bet, analysts' top picks include KNR Constructions, Sadbhav Engineering, and PNC Infratech, among others
The stock of an integrated global pharmaceutical and life sciences company has rallied 14% in past three trading sessions.
Another reason, analysts say, why the cheer may just be short-lived is the buyback offer. For Infosys to get back the trust of long-term investors, they will have to enunciate a business strategy soon
In past one month, the market price of Lupin has fallen 23%, while of Glenmark Pharma by 12% against 2% decline in the S&P BSE Sensex.
The stock surged 14% to Rs 510, also its all-time high on the BSE in early morning trade on back of heavy volumes.